[go: up one dir, main page]

FR2815641B1 - METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS - Google Patents

METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS

Info

Publication number
FR2815641B1
FR2815641B1 FR0013650A FR0013650A FR2815641B1 FR 2815641 B1 FR2815641 B1 FR 2815641B1 FR 0013650 A FR0013650 A FR 0013650A FR 0013650 A FR0013650 A FR 0013650A FR 2815641 B1 FR2815641 B1 FR 2815641B1
Authority
FR
France
Prior art keywords
atheroscleric
lesions
prevention
applications
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0013650A
Other languages
French (fr)
Other versions
FR2815641A1 (en
Inventor
Nathalie Thieblemont
Martin Mempel
Gabriel Gachelin
Philippe Kourilsky
Catherine Ronet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Priority to FR0013650A priority Critical patent/FR2815641B1/en
Priority to PCT/FR2001/003303 priority patent/WO2002034941A1/en
Priority to AU2002214093A priority patent/AU2002214093A1/en
Publication of FR2815641A1 publication Critical patent/FR2815641A1/en
Application granted granted Critical
Publication of FR2815641B1 publication Critical patent/FR2815641B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/0393Animal model comprising a reporter system for screening tests
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pathology (AREA)
  • Animal Husbandry (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FR0013650A 2000-10-24 2000-10-24 METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS Expired - Fee Related FR2815641B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0013650A FR2815641B1 (en) 2000-10-24 2000-10-24 METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS
PCT/FR2001/003303 WO2002034941A1 (en) 2000-10-24 2001-10-24 Method for screening active molecules for treating and preventing atherosclerotic lesions and its uses
AU2002214093A AU2002214093A1 (en) 2000-10-24 2001-10-24 Method for screening active molecules for treating and preventing atherosclerotic lesions and its uses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0013650A FR2815641B1 (en) 2000-10-24 2000-10-24 METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS

Publications (2)

Publication Number Publication Date
FR2815641A1 FR2815641A1 (en) 2002-04-26
FR2815641B1 true FR2815641B1 (en) 2002-12-27

Family

ID=8855703

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0013650A Expired - Fee Related FR2815641B1 (en) 2000-10-24 2000-10-24 METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS

Country Status (3)

Country Link
AU (1) AU2002214093A1 (en)
FR (1) FR2815641B1 (en)
WO (1) WO2002034941A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5675062A (en) * 1994-07-18 1997-10-07 President And Fellows Of Harvard College Cellular basis of transplant arteriosclerosis in mice
FR2792205B1 (en) * 1999-04-19 2001-07-27 Inst Nat Sante Rech Med PHARMACEUTICAL COMPOSITION COMPRISING NKT CELLS ACTIVATED BY IMP, AND ITS USE IN THERAPY

Also Published As

Publication number Publication date
FR2815641A1 (en) 2002-04-26
AU2002214093A1 (en) 2002-05-06
WO2002034941A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
DE60109589D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ACUTE PAIN, CHRONIC PAIN AND / OR NEUROPATHIC PAIN AND MIGRAINE
PT1083889E (en) TETRA-HYDROFOLANTALINE COMPOUNDS AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
ATE306481T1 (en) PYRAZOLECARBOXAMIDE USED TO TREAT OBESITY AND OTHER DISEASES
EP1551416A4 (en) METHOD OF TREATING DYSERECTION AND INCREASING LIBIDO IN MAN
EP1537140A4 (en) NUCLEIC ACID AND CORRESPONDING PROTEIN 161P2F10B USEFUL IN THE TREATMENT AND DETECTION OF CANCER
MA27374A1 (en) ESTER OF 2'-C-METHYL-3'-O-L-VALINE AND RIBOFURANOSYL CYTIDINE FOR THE TREATMENT OF FLAVIVIRIDAE INFECTIONS
EP1100119A4 (en) PLASMA TREATMENT PROCESS
EP1429793A4 (en) NUCLEIC ACID AND CORRESPONDING PROTEIN DESIGNATED BY STEAP-1 USEFUL IN THE TREATMENT AND DETECTION OF CANCER
FR2804603B1 (en) CONTINUOUS PROCESS FOR FORMULATING IN THE FORM OF GRANULES ONE OR MORE PHARMACEUTICAL ACTIVE SUBSTANCES
ITTO20001156A0 (en) EQUIPMENT FOR THE DISGREGATION TREATMENT OF BIOLOGICAL SAMPLES AND DISGREGATION DEVICE FOR USE IN SAID EQUIPMENT.
DE60032910D1 (en) MEDIUM FOR THE DETECTION AND TREATMENT OF DISEASES RELATED TO FGFR3
DE69925578D1 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DISEASES RELATED TO EYE-BASED CELL-DISEASES
EP1572887A4 (en) NEURAL REGENERATION PEPTIDES AND METHODS OF USE THEREOF IN THE TREATMENT OF CEREBRAL LESIONS
FR2772142B1 (en) ANTI-REFLECTIVE TREATMENT METHOD AND MATERIAL PRESENTING ANTI-REFLECTIVE PROPERTIES
FR2797875B1 (en) SPHERICAL TELITHROMYCIN AGGLOMERATES, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION IN THE PREPARATION OF PHARMACEUTICAL FORMS
EP1848440A4 (en) PHARMACEUTICAL COMPOSITION AND METHOD FOR REGENERATING MYOFIBRES IN THE TREATMENT OF MUSCULAR LESIONS
PT1152756E (en) USEFUL ANTICONVULSIVE DERIVATIVES IN THE TREATMENT OF AUTISM
FR2815641B1 (en) METHOD FOR SCREENING ACTIVE MOLECULES IN THE PREVENTION AND TREATMENT OF ATHEROSCLERIC LESIONS AND ITS APPLICATIONS
EP1412293A4 (en) APPARATUS AND METHOD FOR TREATING WASTEWATER BY THE IMPROVED SOLID REDUCTION (ESR) TECHNIQUE
EP1383922A4 (en) NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 158P3D2 USEFUL IN THE TREATMENT AND DETECTION OF CANCER
EP1840948A4 (en) FINE TREATMENT AGENT AND FINE TREATMENT METHOD USING THE SAME
ATE314064T1 (en) L-ACETYLCARNITINE AND L-PROPIONYLCARNITINE COMPOSITION FOR THE PREVENTION AND TREATMENT OF KIDNEY DISORDERS AND KIDNEY DISEASE
FR2724376B1 (en) PROCESS OF IN SITU TREATMENT OF SEDIMENTS AND IN PARTICULAR VASES
AU2002364890A8 (en) Molecules for disease detection and treatment
EP1581634A4 (en) METHOD FOR THE TREATMENT OF PHARMACODEPENDANCE AND SCREENING OF PHARMACEUTICAL AGENTS USEFUL FOR THIS TREATMENT

Legal Events

Date Code Title Description
ST Notification of lapse